Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» OpRegen
OpRegen
Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy
Fierce Pharma
Mon, 11/28/22 - 07:41 pm
Genentech
geographic atrophy
clinical trials
OpRegen
cell therapy